Financial Ratios

NEXUS SURGICAL AND MEDICARE LTD.

NSE : NABSE : 538874ISIN CODE : INE370Q01015Industry : Finance - Stock BrokingHouse : Private
BSE13.48-0.68 (-4.8 %)
PREV CLOSE ( ) 14.16
OPEN PRICE ( ) 14.16
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 22757
TODAY'S LOW / HIGH ( )13.46 14.85
52 WK LOW / HIGH ( ) 8.117.45
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.310.530.28-9.68-0.20
   CEPS(Rs)0.310.540.29-9.67-0.20
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)0.650.33-0.20-0.489.20
   Tax Rate(%)25.3925.239.62-0.31-3.65
Margin Ratios
   Core EBITDA Margin(%)14.0315.414.404.22-8.42
   EBIT Margin(%)14.8216.254.55-304.85-4.98
   Pre Tax Margin(%)14.7316.214.55-304.85-5.03
   PAT Margin (%)10.9912.124.11-305.79-5.21
   Cash Profit Margin (%)11.0812.234.18-305.64-5.09
Performance Ratios
   ROA(%)11.7819.9027.43-186.36-2.02
   ROE(%)63.79781.390.00-221.96-2.19
   ROCE(%)86.021048.040.00-209.80-1.99
   Asset Turnover(x)1.071.646.670.610.39
   Sales/Fixed Asset(x)5.478.5413.386.197.64
   Working Capital/Sales(x)4.84-93.33-16.27-5.19-5.97
Efficiency Ratios
   Fixed Capital/Sales(x)0.180.120.070.160.13
   Receivable days10.180.0011.800.0011.99
   Inventory Days58.3564.880.000.003.78
   Payable days940.03260.42154.4833.79
Valuation Parameters
   PER(x)27.7214.2212.260.000.00
   PCE(x)27.5114.0812.05-1.33-78.45
   Price/Book(x)13.4122.64-17.49-26.951.70
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)2.631.680.454.064.09
   EV/Core EBITDA(x)17.6310.259.6395.62-84.24
   EV/EBIT(x)17.7310.329.78-1.33-82.16
   EV/CE(x)4.502.021.8135.291.60
   M Cap / Sales3.051.720.504.083.99
Growth Ratio
   Net Sales Growth(%)-35.15-36.04116.20-19.03118.60
   Core EBITDA Growth(%)-40.93126.36135.27170.8167.30
   EBIT Growth(%)-40.86128.23103.23-4854.4566.75
   PAT Growth(%)-41.1888.44102.91-4652.1965.83
   EPS Growth(%)-41.1788.47102.91-4651.2065.82
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.05
   Current Ratio(x)1.570.990.780.300.23
   Quick Ratio(x)1.440.750.780.300.22
   Interest Cover(x)168.60350.471218.140.00-111.72
   Total Debt/Mcap(x)0.000.000.000.000.03

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.